Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Licenses Prenatal Genetic Screening IP From Isis

NEW YORK (GenomeWeb News) — Sequenom today said it has licensed Isis Innovation’s intellectual property for non-invasive prenatal genetic testing.
 
Under the agreement, Sequenom licensed rights for Isis’s non-invasive prenatal diagnostic testing on nucleic acids derived from maternal plasma or serum, the company said.
 
Isis is Oxford University’s technology transfer company. It works to develop and market commercial applications for intellectual property owned by the school.
 
Financial terms of the agreement were not released.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.